{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:56:08Z","timestamp":1761976568375,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jhsa.2013.08.117","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T22:30:43Z","timestamp":1383777043000},"page":"121-124","source":"Crossref","is-referenced-by-count":9,"title":["Raynaud Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Ronald R.","family":"Butendieck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jhsa.2013.08.117_bib1","first-page":"485","article-title":"Raynaud's phenomenon: a proposal for classification","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"issue":"9273","key":"10.1016\/j.jhsa.2013.08.117_bib2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud's phenomenon","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jhsa.2013.08.117_bib3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMcp013013","article-title":"Clinical practice: Raynaud's phenomenon","volume":"347","author":"Wigley","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jhsa.2013.08.117_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhsa.2012.08.035","article-title":"Raynaud phenomenon","volume":"38","author":"Porter","year":"2013","journal-title":"J\u00a0Hand Surg Am"},{"issue":"2","key":"10.1016\/j.jhsa.2013.08.117_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/keh390","article-title":"Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis","volume":"44","author":"Thompson","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jhsa.2013.08.117_bib6","first-page":"CD006687","article-title":"Oral vasodilators for primary Raynaud's phenomenon","volume":"7","author":"Stewart","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jhsa.2013.08.117_bib7","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jhsa.2010.09.019","article-title":"Botulinum toxin type A in the treatment of\u00a0Raynaud's phenomenon","volume":"35","author":"Neumeister","year":"2010","journal-title":"J\u00a0Hand Surg Am"},{"issue":"3","key":"10.1016\/j.jhsa.2013.08.117_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10484-006-9018-2","article-title":"Thermal biofeedback for primary Raynaud's phenomenon: a review of the literature","volume":"31","author":"Karavidas","year":"2006","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib9","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.20988","article-title":"The incidence and natural history of Raynaud's phenomenon in the community","volume":"52","author":"Suter","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jhsa.2013.08.117_bib10","first-page":"879","article-title":"Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison","volume":"24","author":"Maricq","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.jhsa.2013.08.117_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"8724","key":"10.1016\/j.jhsa.2013.08.117_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/0140-6736(90)92766-B","article-title":"Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon","volume":"336","author":"Zamora","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhsa.2013.08.117_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0025-7125(16)30623-X","article-title":"Raynaud's phenomenon and disease","volume":"73","author":"Cardelli","year":"1989","journal-title":"Med Clin North Am"},{"issue":"8730","key":"10.1016\/j.jhsa.2013.08.117_bib14","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/0140-6736(90)93307-B","article-title":"Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon","volume":"336","author":"Bunker","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhsa.2013.08.117_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/19.5.249","article-title":"Sympathetic outflow to the hand in patients\u00a0with Raynaud's phenomenon","volume":"19","author":"Fagius","year":"1985","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.jhsa.2013.08.117_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2362.1988.tb01264.x","article-title":"Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits","volume":"18","author":"Coffman","year":"1988","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.jhsa.2013.08.117_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-5347(25)00268-X","article-title":"Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs","volume":"241","author":"Flavahan","year":"1987","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib18","doi-asserted-by":"crossref","first-page":"H1075","DOI":"10.1152\/ajpheart.2000.278.4.H1075","article-title":"Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries","volume":"278","author":"Chotani","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"20","key":"10.1016\/j.jhsa.2013.08.117_bib19","first-page":"761","article-title":"[Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma]","volume":"95","author":"Cuenca","year":"1990","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"10.1016\/j.jhsa.2013.08.117_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0954-6820.1987.tb01245.x","article-title":"The effect of the calcium-entry blocker nifedipine on cold-induced digital vasospasm: a double-blind crossover study versus placebo","volume":"221","author":"Nilsson","year":"1987","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1016\/j.jhsa.2013.08.117_bib21","first-page":"331","article-title":"Nifedipine in the treatment of idiopathic Raynaud's syndrome","volume":"13","author":"Sarkozi","year":"1986","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.jhsa.2013.08.117_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.eurheartj.a062040","article-title":"A\u00a0randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon","volume":"7","author":"Corbin","year":"1986","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0002-8703(86)90109-2","article-title":"Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon","volume":"111","author":"Gjorup","year":"1986","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2125.1986.tb02916.x","article-title":"Clinical and rheological effects of nifedipine in Raynaud's phenomenon","volume":"22","author":"Waller","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"10.1016\/j.jhsa.2013.08.117_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJM198304143081507","article-title":"Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon","volume":"308","author":"Rodeheffer","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jhsa.2013.08.117_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archinte.160.8.1101","article-title":"Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon: results from a randomized clinical trial with 1-year follow-up","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jhsa.2013.08.117_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/000331978904000207","article-title":"Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon","volume":"40","author":"Challenor","year":"1989","journal-title":"Angiology"},{"issue":"suppl C","key":"10.1016\/j.jhsa.2013.08.117_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/eurheartj\/4.suppl_C.123","article-title":"Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon)","volume":"4","author":"Kahan","year":"1983","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib29","first-page":"121","article-title":"Tratamiento del fenomeno de Raynaud con nifedipina: un studio controlado a doble ciego","volume":"13","author":"Redondo","year":"1986","journal-title":"Rev Esp Reumatol"},{"issue":"3","key":"10.1016\/j.jhsa.2013.08.117_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9343(84)90101-3","article-title":"Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon","volume":"77","author":"Ettinger","year":"1984","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.jhsa.2013.08.117_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/oxfordjournals.eurheartj.a061923","article-title":"Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon","volume":"6","author":"Kahan","year":"1985","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/000331978703800407","article-title":"Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial","volume":"38","author":"Kahan","year":"1987","journal-title":"Angiology"},{"issue":"1 pt 2","key":"10.1016\/j.jhsa.2013.08.117_bib33","first-page":"352","article-title":"Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenon: French Cooperative Multicenter Group for Raynaud Phenomenon, Paris, France","volume":"122","year":"1991","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.jhsa.2013.08.117_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00610375","article-title":"Nisoldipine in primary Raynaud's phenomenon","volume":"33","author":"Challenor","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00613511","article-title":"Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon","volume":"31","author":"Gjorup","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jhsa.2013.08.117_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard.44.1.30","article-title":"A\u00a0randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon","volume":"44","author":"Kahan","year":"1985","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jhsa.2013.08.117_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2133.1987.tb07356.x","article-title":"The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon","volume":"117","author":"Rustin","year":"1987","journal-title":"Br J Dermatol"},{"issue":"36","key":"10.1016\/j.jhsa.2013.08.117_bib38","first-page":"2695","article-title":"[Raynaud's disease treated with captopril (Capoten): a randomized double-blind cross-over study]","volume":"146","author":"Madsen","year":"1984","journal-title":"Ugeskr Laeger"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000331979104200405","article-title":"Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up","volume":"42","author":"Le Quentrec","year":"1991","journal-title":"Angiology"},{"issue":"11","key":"10.1016\/j.jhsa.2013.08.117_bib40","first-page":"1917","article-title":"Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon: French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes","volume":"23","author":"Vayssairat","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.jhsa.2013.08.117_bib41","first-page":"313","article-title":"The effectiveness of ketanserin in patients with primary Raynaud's phenomenon: a randomized, double blind, placebo controlled study","volume":"6","author":"van de Wal","year":"1987","journal-title":"Int Angiol"},{"issue":"11-12","key":"10.1016\/j.jhsa.2013.08.117_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1742-1241.1980.tb08202.x","article-title":"Thymoxamine for Raynaud's disease and chilblains","volume":"34","author":"Jaffe","year":"1980","journal-title":"Br J Clin Pract"},{"issue":"6404","key":"10.1016\/j.jhsa.2013.08.117_bib43","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bmj.287.6404.1499","article-title":"Role of cold and emotional stress in Raynaud's disease and scleroderma","volume":"287","author":"Freedman","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.jhsa.2013.08.117_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006842-198807000-00007","article-title":"Nonneural beta-adrenergic vasodilating mechanism in temperature biofeedback","volume":"50","author":"Freedman","year":"1988","journal-title":"Psychosom Med"},{"issue":"3","key":"10.1016\/j.jhsa.2013.08.117_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00846683","article-title":"Behavioral treatment of Raynaud's disease","volume":"1","author":"Surwit","year":"1978","journal-title":"J\u00a0Behav Med"},{"issue":"1","key":"10.1016\/j.jhsa.2013.08.117_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1901\/jaba.1980.13-3","article-title":"Biofeedback, autogenic training, and progressive relaxation in the treatment of Raynaud's disease: a comparative study","volume":"13","author":"Keefe","year":"1980","journal-title":"J\u00a0Appl Behav Anal"},{"issue":"1","key":"10.1016\/j.jhsa.2013.08.117_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00844647","article-title":"Comparison of behavioral treatments for Raynaud's disease","volume":"9","author":"Jobe","year":"1986","journal-title":"J\u00a0Behav Med"},{"issue":"6","key":"10.1016\/j.jhsa.2013.08.117_bib48","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/ajp.136.6.844","article-title":"Behavioral treatment for Raynaud's disease: a comparative study with long-term follow-up","volume":"136","author":"Jacobson","year":"1979","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.jhsa.2013.08.117_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00999058","article-title":"Skin temperature biofeedback for Raynaud's disease: a double-blind study","volume":"7","author":"Guglielmi","year":"1982","journal-title":"Biofeedback Self Regul"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502313011854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502313011854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T19:43:43Z","timestamp":1746042223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502313011854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0363502313011854"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2013.08.117","relation":{},"ISSN":["0363-5023"],"issn-type":[{"type":"print","value":"0363-5023"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}